V021-1209 Screening compound: 2-{[4-(4-methylphenoxy)-2-(morpholin-4-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-6-yl]sulfonyl}benzonitrile

V021-1209 Screening compound: 2-{[4-(4-methylphenoxy)-2-(morpholin-4-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-6-yl]sulfonyl}benzonitrile
V021-1209 Screening compound: 2-{[4-(4-methylphenoxy)-2-(morpholin-4-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-6-yl]sulfonyl}benzonitrile alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-1209
2-{[4-(4-methylphenoxy)-2-(morpholin-4-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-6-yl]sulfonyl}benzonitrile

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-1209

Molecular Formula

C25H25N5O4S (C25 H25 N5 O4 S)

Compound Name

2-{[4-(4-methylphenoxy)-2-(morpholin-4-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-6-yl]sulfonyl}benzonitrile

IUPAC name

2-{[4-(4-methylphenoxy)-2-(morpholin-4-yl)-5H6H7H8H-pyrido[43-d]pyrimidin-6-yl]sulfonyl}benzonitrile

SMILES

Cc(cc1)ccc1Oc1c(CN(CC2)S(c(cccc3)c3C#N)(=O)=O)c2nc(N2CCOCC2)n1

InChI

InChI=1S/C25H25N5O4S/c1-18-6-8-20(9-7-18)34-24-21-17-30(35(31,32)23-5-3-2-4-19(23)16-26)11-10-22(21)27-25(28-24)29-12-14-33-15-13-29/h2-9H,10-15,17H2,1H3

InChI Key

CYWOMZVAASVIAK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19908757

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

491.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.283

Distribution Coefficient, logD

4.283

Water Solubility, LogSw

-4.37

Polar Surface Area

86.533

Acid Dissociation Constant (pKa)

20.43

Base Dissociation Constant (pKb)

2.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

V021-1209 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V021-1209 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-1209?
Check Price and Availability of V021-1209, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-1209 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-1209
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-1209
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-1209 available by request